Yaxian Gao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Yaxian Gao has a total of 41 co-authors. Here are the top co-authors by number of shared publications:
Bing Bai
Department of Immunology, Basic Medical Institute, Chengde Medical University, Chengde 067000, Hebei, China
6 shared publicationsYongwei Wang
Department of Anatomy, Basic Medical Institute, Chengde Medical University, Chengde 067000, Hebei, China
6 shared publicationsSihan Bo
Department of Immunology, Basic Medical Institute, Chengde Medical University, Chengde 067000, Hebei, China; Department of Mental Health Prevention and Control, The Third Hospital of Quzhou, Quzhou 324000, Zhejiang, China
5 shared publicationsYong You
Department of Immunology, Basic Medical Institute, Chengde Medical University, Chengde 067000, Hebei, China
5 shared publicationsTao Jiang
Department of Ultrasound, The First Affiliated Hospital of Anhui Medical University, Hefei 230000, Anhui, China
4 shared publicationsSen Guo
Department of Anatomy, Basic Medical Institute, Chengde Medical College, Chengde, China
3 shared publications
Latest Publications
- 22 June 2026
- Published by Elsevier in Experimental Cell Research
- Vol. 461 (2) , 115104
FAM105A regulates the Hippo/YAP signaling pathway via deubiquitination to promote gastric cancer cell proliferation and migration
- 22 June 2026
- Published by Elsevier in Experimental Cell Research
- Vol. 461 (2) , 115104
FAM105A regulates the Hippo/YAP signaling pathway via deubiquitination to promote gastric cancer cell proliferation and migration
- 6 January 2026
- Published by Elsevier in Cancer Genetics
- Vol. 302-303, 40-49
Investigation of hnRNPK's role in gastric cancer proliferation and migration and its interaction with TL1A
- 6 January 2026
- Published by Elsevier in Cancer Genetics
- Vol. 302-303, 40-49
Investigation of hnRNPK's role in gastric cancer proliferation and migration and its interaction with TL1A
- Open Access
- 26 April 2025
- Published by Elsevier in Immunobiology
- Vol. 230 (3) , 152909
Interpretable Machine Learning reveals the Role of PANoptosis in the Diagnosis and Subtyping of NAFLD
- 26 April 2025
- Published by Elsevier in Immunobiology
- Vol. 230 (3) , 152909
Open AccessInterpretable Machine Learning reveals the Role of PANoptosis in the Diagnosis and Subtyping of NAFLD
- 26 February 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 446 (2) , 114491
ELAVL1 facilitates gastric cancer progression and metastasis through TL1A mRNA stabilization
- 26 February 2025
- Published by Elsevier in Experimental Cell Research
- Vol. 446 (2) , 114491
ELAVL1 facilitates gastric cancer progression and metastasis through TL1A mRNA stabilization
- 13 February 2025
- Published by Springer Nature in Apoptosis
- Vol. 30 (3-4) , 1021-1041
Integrating single-cell sequencing and machine learning to uncover the role of mitophagy in subtyping and prognosis of esophageal cancer
Globally, esophageal cancer stands as a prominent contributor to cancer-related fatalities, distinguished by its poor prognosis. Mitophagy has a significant impact on the process of cancer progression. This study investigated the prognostic significance of mitophagy-related genes (MRGs) in esophageal carcinoma (ESCA) to elucidate molecular subtypes. By analyzing RNA-seq data from The Cancer Genome Atlas (TCGA), 6451 differentially expressed genes (DEGs) were identified. Cox regression analysis narrowed this list to 14 MRGs with potential prognostic implications. ESCA patients were classified into two distinct subtypes (C1 and C2) based on these genes. Furthermore, leveraging the differentially expressed genes between Cluster 1 and Cluster 2, ESCA patients were classified into two novel subtypes (CA and CB). Importantly, patients in C2 and CA subtypes exhibited inferior prognosis compared to those in C1 and CB (p < 0.05). Functional enrichments and immune microenvironments varied significantly among these subtypes, with C1 and CB demonstrating higher immune checkpoint expression levels. Employing machine learning algorithms like LASSO regression, Random Forest and XGBoost, alongside multivariate COX regression analysis, two core genes: HSPD1 and MAP1LC3B were identified. A prognostic model based on these genes was developed and validated in two external cohorts. Additionally, single-cell sequencing analysis provided novel insights into esophageal cancer microenvironment heterogeneity. Through Coremine database screening, Icaritin emerged as a potential therapeutic candidate to potentially improve esophageal cancer prognosis. Molecular docking results indicated favorable binding efficacies of Icaritin with HSPD1 and MAP1LC3B, contributing to the understanding of the underlying molecular mechanisms of esophageal cancer and offering therapeutic avenues.
- 13 February 2025
- Published by Springer Nature in Apoptosis
- Vol. 30 (3-4) , 1021-1041
Integrating single-cell sequencing and machine learning to uncover the role of mitophagy in subtyping and prognosis of esophageal cancer
Globally, esophageal cancer stands as a prominent contributor to cancer-related fatalities, distinguished by its poor prognosis. Mitophagy has a significant impact on the process of cancer progression. This study investigated the prognostic significance of mitophagy-related genes (MRGs) in esophageal carcinoma (ESCA) to elucidate molecular subtypes. By analyzing RNA-seq data from The Cancer Genome Atlas (TCGA), 6451 differentially expressed genes (DEGs) were identified. Cox regression analysis narrowed this list to 14 MRGs with potential prognostic implications. ESCA patients were classified into two distinct subtypes (C1 and C2) based on these genes. Furthermore, leveraging the differentially expressed genes between Cluster 1 and Cluster 2, ESCA patients were classified into two novel subtypes (CA and CB). Importantly, patients in C2 and CA subtypes exhibited inferior prognosis compared to those in C1 and CB (p < 0.05). Functional enrichments and immune microenvironments varied significantly among these subtypes, with C1 and CB demonstrating higher immune checkpoint expression levels. Employing machine learning algorithms like LASSO regression, Random Forest and XGBoost, alongside multivariate COX regression analysis, two core genes: HSPD1 and MAP1LC3B were identified. A prognostic model based on these genes was developed and validated in two external cohorts. Additionally, single-cell sequencing analysis provided novel insights into esophageal cancer microenvironment heterogeneity. Through Coremine database screening, Icaritin emerged as a potential therapeutic candidate to potentially improve esophageal cancer prognosis. Molecular docking results indicated favorable binding efficacies of Icaritin with HSPD1 and MAP1LC3B, contributing to the understanding of the underlying molecular mechanisms of esophageal cancer and offering therapeutic avenues.
- 10 January 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 147, 114028
Effects of dioscin from Dioscorea nipponica on TL1A/DR3 and Th9 cells in a collagen-induced arthritis mouse model
- 10 January 2025
- Published by Elsevier in International Immunopharmacology
- Vol. 147, 114028
Effects of dioscin from Dioscorea nipponica on TL1A/DR3 and Th9 cells in a collagen-induced arthritis mouse model
- Open Access
- 2 January 2024
- Published by Springer Nature in Research Square
Hub gene mining and immune microenvironment analysis of autophagy in rheumatoid arthritis
Background Autophagy is closely associated with the pathogenesis and progression of rheumatoid arthritis (RA). However, the mechanisms of RA and autophagy are currently unclear. Therefore, it is essential to identify appropriate biomarkers for early diagnosis. Methods Autophagy-related genes (ARGs) were intersected with differentially expressed genes (DEGs). The resulting intersection was subjected to GO, KEGG, and GSEA analysis, and the protein-protein interaction (PPI) network was drawn to further analyze hub genes. The performance evaluation of the hub gene was identified to explore its potential value. Based on this, different correlations with immune cell infiltration were analyzed. Results Five relatively stable hub genes–CXCL10, CXCL9, GZMB, IL7R, and CD2–were identified. Expression levels of these genes also differed. Through functional enrichment analysis, we found that they were related to autophagy and natural immune inflammation and that the expression of the hub gene was associated with the expression of the infiltrating immune cell abundance gene. Conclusion In our study, five hub genes were identified, which may help develop therapeutic agents targeting autophagy for the early diagnosis and treatment of patients with RA.
- 2 January 2024
- Published by Springer Nature in Research Square
Open AccessHub gene mining and immune microenvironment analysis of autophagy in rheumatoid arthritis
Background Autophagy is closely associated with the pathogenesis and progression of rheumatoid arthritis (RA). However, the mechanisms of RA and autophagy are currently unclear. Therefore, it is essential to identify appropriate biomarkers for early diagnosis. Methods Autophagy-related genes (ARGs) were intersected with differentially expressed genes (DEGs). The resulting intersection was subjected to GO, KEGG, and GSEA analysis, and the protein-protein interaction (PPI) network was drawn to further analyze hub genes. The performance evaluation of the hub gene was identified to explore its potential value. Based on this, different correlations with immune cell infiltration were analyzed. Results Five relatively stable hub genes–CXCL10, CXCL9, GZMB, IL7R, and CD2–were identified. Expression levels of these genes also differed. Through functional enrichment analysis, we found that they were related to autophagy and natural immune inflammation and that the expression of the hub gene was associated with the expression of the infiltrating immune cell abundance gene. Conclusion In our study, five hub genes were identified, which may help develop therapeutic agents targeting autophagy for the early diagnosis and treatment of patients with RA.
- Open Access
- 1 January 2024
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 19 (1) , 20241056
Identification of signatures associated with microsatellite instability and immune characteristics to predict the prognostic risk of colon cancer
Background: Microsatellite instability (MSI) significantly impacts treatment response and outcomes in colon cancer; however, its underlying molecular mechanisms remain unclear. This study aimed to identify prognostic biomarkers by comparing MSI and microsatellite stability (MSS). Methods: Data from the GSE39582 dataset downloaded from the Gene Expression Omnibus database were analyzed for differentially expressed genes (DEGs) and immune cell infiltration between MSI and MSS. Then, weighted gene co-expression network analysis (WGCNA) was utilized to identify the key modules, and the modules related to immune infiltration phenotypes were considered as the immune-related gene modules, followed by enrichment analysis of immune-related module genes. Prognostic signatures were derived using Cox regression, and their correlation with immune features and clinical features was assessed, followed by a nomogram construction. Results: A total of 857 DEGs and 14 differential immune cell infiltration between MSI and MSS were obtained. Then, WGCNA identified two immune-related modules comprising 356 genes, namely MEturquoise and MEbrown. Eight signature genes were identified, namely PLK2, VSIG4, LY75, GZMB, GAS1, LIPG, ANG, and AMACR, followed by prognostic model construction. Both training and validation cohorts revealed that these eight signature genes have prognostic value, and the prognostic model showed superior predictive performance for colon cancer prognosis and distinguished the clinical characteristics of colon cancer patients. Notably, VSIG4 among the signature genes correlated significantly with immune infiltration, human leukocyte antigen expression, and immune pathway enrichment. Finally, the constructed nomogram model could significantly predict the prognosis of colorectal cancer. Conclusion: This study identifies eight prognostic signature genes associated with MSI and immune infiltration in colon cancer, suggesting their potential for predicting prognostic risk.
- 1 January 2024
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 19 (1) , 20241056
Open AccessIdentification of signatures associated with microsatellite instability and immune characteristics to predict the prognostic risk of colon cancer
Background: Microsatellite instability (MSI) significantly impacts treatment response and outcomes in colon cancer; however, its underlying molecular mechanisms remain unclear. This study aimed to identify prognostic biomarkers by comparing MSI and microsatellite stability (MSS). Methods: Data from the GSE39582 dataset downloaded from the Gene Expression Omnibus database were analyzed for differentially expressed genes (DEGs) and immune cell infiltration between MSI and MSS. Then, weighted gene co-expression network analysis (WGCNA) was utilized to identify the key modules, and the modules related to immune infiltration phenotypes were considered as the immune-related gene modules, followed by enrichment analysis of immune-related module genes. Prognostic signatures were derived using Cox regression, and their correlation with immune features and clinical features was assessed, followed by a nomogram construction. Results: A total of 857 DEGs and 14 differential immune cell infiltration between MSI and MSS were obtained. Then, WGCNA identified two immune-related modules comprising 356 genes, namely MEturquoise and MEbrown. Eight signature genes were identified, namely PLK2, VSIG4, LY75, GZMB, GAS1, LIPG, ANG, and AMACR, followed by prognostic model construction. Both training and validation cohorts revealed that these eight signature genes have prognostic value, and the prognostic model showed superior predictive performance for colon cancer prognosis and distinguished the clinical characteristics of colon cancer patients. Notably, VSIG4 among the signature genes correlated significantly with immune infiltration, human leukocyte antigen expression, and immune pathway enrichment. Finally, the constructed nomogram model could significantly predict the prognosis of colorectal cancer. Conclusion: This study identifies eight prognostic signature genes associated with MSI and immune infiltration in colon cancer, suggesting their potential for predicting prognostic risk.
- Open Access
- 10 February 2021
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10
Re-Clustering and Profiling of Digestive System Tumors According to Microenvironment Components
Background: Immunotherapy has become the most promising therapy in digestive system tumors besides conventional chemotherapy and radiotherapy. But only a few patients can benefit from different types of immunotherapies, such as immune checkpoint blockade (ICB). To identify these ICB-susceptible patients, methods are urgently needed to screen and profile subgroups of patients with different responsiveness to ICB. Methods: This study carried out analysis on patients with digestive system tumors that were obtained from Cancer Genome Atlas (TCGA) cohorts. The analyses were mainly performed using GraphPad Prism 7 and R language. Results: We have quantified the microenvironmental components of eight digestive system tumor patients in TCGA cohorts and evaluated their clinical value. We re-clustered patients based on their microenvironment composition and divided these patients into six clusters. The differences between these six clusters were profiled, including survival conditions, enriched biological processes, genomic mutations, and microenvironment traits. Cluster 3 was the most immune-related cluster, exhibiting a high infiltration of non-tumor components and poor survival status, along with an inhibitory immune status, and we found that patients with high stromal score indicated a poor response in ICB cohort. Conclusions: Our research provides a new strategy based on the microenvironment components for the reclassification of digestive system tumors, which could provide guidance for prognosis judgment and treatment response prediction like ICB.
- 10 February 2021
- Published by Frontiers Media SA in Frontiers in Oncology
- Vol. 10
Open AccessRe-Clustering and Profiling of Digestive System Tumors According to Microenvironment Components
Background: Immunotherapy has become the most promising therapy in digestive system tumors besides conventional chemotherapy and radiotherapy. But only a few patients can benefit from different types of immunotherapies, such as immune checkpoint blockade (ICB). To identify these ICB-susceptible patients, methods are urgently needed to screen and profile subgroups of patients with different responsiveness to ICB. Methods: This study carried out analysis on patients with digestive system tumors that were obtained from Cancer Genome Atlas (TCGA) cohorts. The analyses were mainly performed using GraphPad Prism 7 and R language. Results: We have quantified the microenvironmental components of eight digestive system tumor patients in TCGA cohorts and evaluated their clinical value. We re-clustered patients based on their microenvironment composition and divided these patients into six clusters. The differences between these six clusters were profiled, including survival conditions, enriched biological processes, genomic mutations, and microenvironment traits. Cluster 3 was the most immune-related cluster, exhibiting a high infiltration of non-tumor components and poor survival status, along with an inhibitory immune status, and we found that patients with high stromal score indicated a poor response in ICB cohort. Conclusions: Our research provides a new strategy based on the microenvironment components for the reclassification of digestive system tumors, which could provide guidance for prognosis judgment and treatment response prediction like ICB.
- Open Access
- 22 September 2020
- Published by Springer Nature in Research Square
Re-clustering and profiling of digestive system tumors according to microenvironment components
BackgroundsImmunotherapy has become the most promising therapy in digestive system tumors besides conventional chemotherapy and radiotherapy. However, only a few patients could benefit from this kind of immunotherapy such as immune checkpoint blocking (ICB) treatment. It is urgent to screening and profiling the subgroups of patients with different responsiveness to ICB treatment.MethodsThis study carried out analysis on digestive system tumor patients from the Cancer Genome Atlas (TCGA) cohorts. The analyses were mainly performed by GraphPad Prism 7 and R language.ResultsWe have quantified the microenvironmental components of eight digestive system tumor patients in TCGA cohort and evaluated their clinical value. We re-clustered patients based on the characteristics of the microenvironment composition and divided these patients into 6 clusters. The difference between these 6 clusters were profiled including survival conditions, enriched biological process, genomic mutation and microenvironment traits. We also evaluated the response heterogeneity in ICB cohorts grouping by microenvironmental factors.ConclusionsCluster 3 was the most immune related cluster with high infiltration of non-tumor components and poor survival status, which was also exhibited an inhibitory immune status. High stromal score could represent cluster 3 and indicated a poor response in ICB cohorts.
- 22 September 2020
- Published by Springer Nature in Research Square
Open AccessRe-clustering and profiling of digestive system tumors according to microenvironment components
BackgroundsImmunotherapy has become the most promising therapy in digestive system tumors besides conventional chemotherapy and radiotherapy. However, only a few patients could benefit from this kind of immunotherapy such as immune checkpoint blocking (ICB) treatment. It is urgent to screening and profiling the subgroups of patients with different responsiveness to ICB treatment.MethodsThis study carried out analysis on digestive system tumor patients from the Cancer Genome Atlas (TCGA) cohorts. The analyses were mainly performed by GraphPad Prism 7 and R language.ResultsWe have quantified the microenvironmental components of eight digestive system tumor patients in TCGA cohort and evaluated their clinical value. We re-clustered patients based on the characteristics of the microenvironment composition and divided these patients into 6 clusters. The difference between these 6 clusters were profiled including survival conditions, enriched biological process, genomic mutation and microenvironment traits. We also evaluated the response heterogeneity in ICB cohorts grouping by microenvironmental factors.ConclusionsCluster 3 was the most immune related cluster with high infiltration of non-tumor components and poor survival status, which was also exhibited an inhibitory immune status. High stromal score could represent cluster 3 and indicated a poor response in ICB cohorts.